Organicell Regenerative Medicine, Inc

For profitWebsite ↗

Also known as: Chief Medical Officer at Organicell Regenerative Medicine, Inc | Chief Science Officer at Organicell Regenerative Medicine, Inc | Co-Investigator | Organicell Regenerative Medicine

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

May 31, 2020

Last known activity

Dec 18, 2022

Timeline

2010s

Jun 1, 2011
Organicell Regenerative Medicine, Inc— Founded

Drugs by trial phase (3 distinct, 5 trials)

Phase 2 (3 own, 0 via acquisition)

amniotic fluid
organicell
erucov-vac

Indications

Studied for

Acute Lung Injury
Coronavirus Infections
Infections
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Newborn
Severe Acute Respiratory Syndrome

Recent trials (6)

NCT04657406Lead sponsorN/A—
NCT05643729Lead sponsorPhase 1/Phase 2Dec 18, 2022
NCT05228899Lead sponsorPhase 1/Phase 2Apr 14, 2022
NCT04824391Study directorPhase 2Feb 10, 2021
NCT04384445Overall official - principal investigatorPhase 1/Phase 2May 31, 2020
NCT04384445Lead sponsorPhase 1/Phase 2May 31, 2020

Details

Founded: Miami, FL, US Jun 1, 2011
Last known activity: Dec 18, 2022